Celltrion Announces FDA Nod for New STEQEYMA Presentation to Broaden Pediatric Use; CSL’s ANDEMBRY Gets FDA Nod as First Factor XIIa Inhibitor for Hereditary Angioedema; Ocugen’s OCU410ST Cleared by FDA to Begin Phase II/III Trial in Stargardt Disease; Milestone Pharmaceuticals Submits FDA Response for CARDAMYST in PSVT; AbbVie’s MAVYRET Approved by FDA as First and Only Therapy for Acute Hepatitis C

Each Year 24^th March is recognized as World Tuberculosis Day. Tuberculosis resulted in 1.6 million deaths in 2017 worldwide. This year let us make an aim to end TB. Work for Zero deaths from TB.  The cure for TB exists. Spread the word, not the disease.